CN104587110B - 一种治疗耳眩晕的药物及其制备方法 - Google Patents
一种治疗耳眩晕的药物及其制备方法 Download PDFInfo
- Publication number
- CN104587110B CN104587110B CN201510094344.8A CN201510094344A CN104587110B CN 104587110 B CN104587110 B CN 104587110B CN 201510094344 A CN201510094344 A CN 201510094344A CN 104587110 B CN104587110 B CN 104587110B
- Authority
- CN
- China
- Prior art keywords
- parts
- medicine
- radix
- ménière
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000003814 drug Substances 0.000 title claims abstract description 70
- 238000002360 preparation method Methods 0.000 title claims abstract description 25
- 229940079593 drug Drugs 0.000 claims abstract description 30
- 210000000582 semen Anatomy 0.000 claims abstract description 28
- 241000628997 Flos Species 0.000 claims abstract description 14
- 239000008517 radix Trichosanthis Substances 0.000 claims abstract description 14
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 26
- 239000012567 medical material Substances 0.000 claims description 17
- 239000000706 filtrate Substances 0.000 claims description 16
- 239000002775 capsule Substances 0.000 claims description 12
- 239000000843 powder Substances 0.000 claims description 10
- 239000002671 adjuvant Substances 0.000 claims description 8
- 239000000203 mixture Substances 0.000 claims description 8
- 238000000034 method Methods 0.000 claims description 6
- 241001601725 Sthenias Species 0.000 claims description 4
- 239000008187 granular material Substances 0.000 claims description 4
- 239000006187 pill Substances 0.000 claims description 3
- 239000007787 solid Substances 0.000 claims description 3
- 239000003826 tablet Substances 0.000 claims description 3
- 239000002552 dosage form Substances 0.000 claims description 2
- 230000001225 therapeutic effect Effects 0.000 abstract description 4
- 206010061623 Adverse drug reaction Diseases 0.000 abstract 1
- 208000030453 Drug-Related Side Effects and Adverse reaction Diseases 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 17
- 210000004185 liver Anatomy 0.000 description 15
- 208000002193 Pain Diseases 0.000 description 9
- 238000005516 engineering process Methods 0.000 description 9
- 239000008280 blood Substances 0.000 description 8
- 210000004369 blood Anatomy 0.000 description 8
- 230000001737 promoting effect Effects 0.000 description 8
- 230000017531 blood circulation Effects 0.000 description 6
- 208000002173 dizziness Diseases 0.000 description 6
- 230000003203 everyday effect Effects 0.000 description 6
- 239000002994 raw material Substances 0.000 description 6
- 238000011084 recovery Methods 0.000 description 6
- 201000000736 Amenorrhea Diseases 0.000 description 5
- 206010001928 Amenorrhoea Diseases 0.000 description 5
- 208000005171 Dysmenorrhea Diseases 0.000 description 5
- 206010013935 Dysmenorrhoea Diseases 0.000 description 5
- 208000012886 Vertigo Diseases 0.000 description 5
- 210000001015 abdomen Anatomy 0.000 description 5
- 231100000540 amenorrhea Toxicity 0.000 description 5
- 235000009508 confectionery Nutrition 0.000 description 5
- 201000010099 disease Diseases 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 208000024891 symptom Diseases 0.000 description 5
- 206010010774 Constipation Diseases 0.000 description 4
- 206010010904 Convulsion Diseases 0.000 description 4
- 208000027418 Wounds and injury Diseases 0.000 description 4
- 230000006378 damage Effects 0.000 description 4
- 208000014674 injury Diseases 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 206010020772 Hypertension Diseases 0.000 description 3
- 206010062717 Increased upper airway secretion Diseases 0.000 description 3
- 208000019255 Menstrual disease Diseases 0.000 description 3
- 230000036461 convulsion Effects 0.000 description 3
- 210000003027 ear inner Anatomy 0.000 description 3
- 208000026435 phlegm Diseases 0.000 description 3
- 230000008961 swelling Effects 0.000 description 3
- 231100000889 vertigo Toxicity 0.000 description 3
- 208000004998 Abdominal Pain Diseases 0.000 description 2
- 206010067484 Adverse reaction Diseases 0.000 description 2
- 208000006820 Arthralgia Diseases 0.000 description 2
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 2
- 206010010726 Conjunctival oedema Diseases 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- 206010011878 Deafness Diseases 0.000 description 2
- 206010019233 Headaches Diseases 0.000 description 2
- 206010020751 Hypersensitivity Diseases 0.000 description 2
- 208000027530 Meniere disease Diseases 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- 206010037660 Pyrexia Diseases 0.000 description 2
- 208000025747 Rheumatic disease Diseases 0.000 description 2
- 206010061373 Sudden Hearing Loss Diseases 0.000 description 2
- 208000009205 Tinnitus Diseases 0.000 description 2
- 208000014070 Vestibular schwannoma Diseases 0.000 description 2
- 206010047700 Vomiting Diseases 0.000 description 2
- 208000004064 acoustic neuroma Diseases 0.000 description 2
- 230000006838 adverse reaction Effects 0.000 description 2
- 208000026935 allergic disease Diseases 0.000 description 2
- 230000007815 allergy Effects 0.000 description 2
- 208000007502 anemia Diseases 0.000 description 2
- 210000000481 breast Anatomy 0.000 description 2
- 239000002131 composite material Substances 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- 210000000232 gallbladder Anatomy 0.000 description 2
- 231100000869 headache Toxicity 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- 230000002045 lasting effect Effects 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 210000002751 lymph Anatomy 0.000 description 2
- 235000012054 meals Nutrition 0.000 description 2
- 206010029864 nystagmus Diseases 0.000 description 2
- 210000003516 pericardium Anatomy 0.000 description 2
- 239000008194 pharmaceutical composition Substances 0.000 description 2
- 208000037920 primary disease Diseases 0.000 description 2
- 230000000552 rheumatic effect Effects 0.000 description 2
- 230000000630 rising effect Effects 0.000 description 2
- 206010040872 skin infection Diseases 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 231100000886 tinnitus Toxicity 0.000 description 2
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 description 1
- WTQYWNWRJNXDEG-UHFFFAOYSA-N 6-Hydroxy-hyoscyamin Natural products CN1C(C2)CC(O)C1CC2OC(=O)C(CO)C1=CC=CC=C1 WTQYWNWRJNXDEG-UHFFFAOYSA-N 0.000 description 1
- 206010000077 Abdominal mass Diseases 0.000 description 1
- 206010002368 Anger Diseases 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 206010010071 Coma Diseases 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- 206010011891 Deafness neurosensory Diseases 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 208000034507 Haematemesis Diseases 0.000 description 1
- 206010025476 Malabsorption Diseases 0.000 description 1
- 208000004155 Malabsorption Syndromes Diseases 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 206010034960 Photophobia Diseases 0.000 description 1
- 206010040007 Sense of oppression Diseases 0.000 description 1
- 208000009966 Sensorineural Hearing Loss Diseases 0.000 description 1
- 206010042674 Swelling Diseases 0.000 description 1
- 206010043458 Thirst Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- WTQYWNWRJNXDEG-LEOABGAYSA-N anisodamine Chemical compound C1([C@@H](CO)C(=O)O[C@@H]2C[C@H]3[C@@H](O)C[C@@H](C2)N3C)=CC=CC=C1 WTQYWNWRJNXDEG-LEOABGAYSA-N 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 238000009534 blood test Methods 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 210000000038 chest Anatomy 0.000 description 1
- 229940121657 clinical drug Drugs 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 231100000895 deafness Toxicity 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 230000001544 dysphoric effect Effects 0.000 description 1
- 210000000959 ear middle Anatomy 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- 208000001780 epistaxis Diseases 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 208000016354 hearing loss disease Diseases 0.000 description 1
- 238000012074 hearing test Methods 0.000 description 1
- 230000001709 ictal effect Effects 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 238000010255 intramuscular injection Methods 0.000 description 1
- 239000007927 intramuscular injection Substances 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000002175 menstrual effect Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 201000011461 pre-eclampsia Diseases 0.000 description 1
- 230000001047 pyretic effect Effects 0.000 description 1
- 230000007115 recruitment Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 208000023573 sensorineural hearing loss disease Diseases 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 230000001720 vestibular Effects 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
Description
Claims (7)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510094344.8A CN104587110B (zh) | 2015-03-03 | 2015-03-03 | 一种治疗耳眩晕的药物及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510094344.8A CN104587110B (zh) | 2015-03-03 | 2015-03-03 | 一种治疗耳眩晕的药物及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104587110A CN104587110A (zh) | 2015-05-06 |
CN104587110B true CN104587110B (zh) | 2015-09-23 |
Family
ID=53113381
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510094344.8A Expired - Fee Related CN104587110B (zh) | 2015-03-03 | 2015-03-03 | 一种治疗耳眩晕的药物及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104587110B (zh) |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102631561B (zh) * | 2012-04-10 | 2013-10-30 | 李远景 | 一种治疗颈性眩晕的中药 |
CN104173771A (zh) * | 2014-09-03 | 2014-12-03 | 廖玉兰 | 治疗耳源性眩晕升清降浊的中药组合物及制备方法 |
-
2015
- 2015-03-03 CN CN201510094344.8A patent/CN104587110B/zh not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CN104587110A (zh) | 2015-05-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN106728770B (zh) | 一种补肾益精的中药组合物及其制备方法 | |
CN102357236A (zh) | 一种治疗面神经炎的中药 | |
CN104436040A (zh) | 一种治疗干眼症的药物 | |
CN111588828A (zh) | 一种治疗新冠病毒和病毒性疾病的中药制剂及制备方法 | |
CN104147388B (zh) | 一种治疗偏头疼的中药组合物及其制备方法 | |
CN104587110B (zh) | 一种治疗耳眩晕的药物及其制备方法 | |
CN103920102A (zh) | 一种治疗原发性低血压的中药药物 | |
CN105853930A (zh) | 一种治疗抑郁症的中药组合物 | |
CN105434739A (zh) | 一种治疗霰粒肿的中药组合物及其制备方法 | |
CN101181489A (zh) | 一种内服治疗青光眼的中药组合物 | |
CN104998158A (zh) | 一种治疗肝硬化的药物组合物及其应用 | |
CN100473401C (zh) | 一种预防和治疗脑血栓及后遗症的中药制剂 | |
CN103655980A (zh) | 一种治疗痰浊中阻证型内耳眩晕症的中药 | |
CN103736001B (zh) | 一种治疗失眠的中药组合物 | |
CN103263645B (zh) | 一种治疗胃炎、胃溃疡的药物 | |
CN104127713A (zh) | 一种治疗血管性偏头痛的中药组合物 | |
CN105878738A (zh) | 一种治疗气血不足证的中药组合物及其制备方法 | |
CN104840873A (zh) | 一种治疗美尼尔氏综合症的中药制剂及其制备方法 | |
CN105213975A (zh) | 一种治疗肝硬化的药物组合物及其应用 | |
CN105362703A (zh) | 一种治疗原发性高血压的中药组合物及其制备方法 | |
CN103948783A (zh) | 一种预防和/或治疗脑梗塞的药物组合物 | |
CN104435133A (zh) | 一种退烧药 | |
CN104173995A (zh) | 一种治疗痛经的中药制剂 | |
CN104127716A (zh) | 一种治疗三叉神经痛的中药制剂 | |
CN104306905A (zh) | 一种治疗高血压中药组合物及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: JIE BO Free format text: FORMER OWNER: CHEN HONG Effective date: 20150820 |
|
C41 | Transfer of patent application or patent right or utility model | ||
C53 | Correction of patent for invention or patent application | ||
CB03 | Change of inventor or designer information |
Inventor after: Jiang Anshi Inventor after: Xu Yanli Inventor before: Chen Hong |
|
COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: CHEN HONG TO: JIANG ANSHI XU YANLI |
|
TA01 | Transfer of patent application right |
Effective date of registration: 20150820 Address after: 235162 Anhui Province, Huaibei City Xiangshan District Anhui Hengyuan coal Limited by Share Ltd dormitory Applicant after: Jie Bo Address before: 266000 Qingdao City, Sifang District, Shandong flood water ditch village, No. 2, 106 Applicant before: Chen Hong |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CB03 | Change of inventor or designer information |
Inventor after: Zhang Changying Inventor before: Jiang Anshi Inventor before: Xu Yanli |
|
CB03 | Change of inventor or designer information | ||
TR01 | Transfer of patent right |
Effective date of registration: 20180123 Address after: 221125 tagan village, Tashan Town, Jiawang District, Xuzhou, Jiangsu Patentee after: XUZHOU FENGRUN BIOLOGICAL ORGANIC FERTILIZER TECHNOLOGY DEVELOPMENT CO., LTD. Address before: 235162 Anhui Province, Huaibei City Xiangshan District Anhui Hengyuan coal Limited by Share Ltd dormitory Patentee before: Jie Bo |
|
TR01 | Transfer of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20150923 Termination date: 20190303 |